bibliographicCitation |
Liu X, Qiu R, Xu M, Meng M, Zhao S, Ji J, Yang Y. KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer. Breast Cancer Research and Treatment. 2021 Jul 08;189(2):347–61. doi: 10.1007/s10549-021-06325-1. |